Point of Service Diabetes Screening Evaluation

VeraLight, Inc.667 enrolled

Overview

The primary objective of the trial is to collect SCOUT DS, random capillary glucose and Hemoglobin A1c measurements from subject 18 years of age or older.

The objectives of this study are to compare the accuracy of SCOUT versus random capillary glucose and several diabetes risk assessment questionnaires for detection of HbA1C-defined dysglycemia.

Study Type

OBSERVATIONAL

Enrollment

667

Conditions

Diabetes Mellitus, Non-Insulin Dependent

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age or older Exclusion Criteria: * Known to be pregnant (self-reported) * Receiving dialysis or known renal compromise * Known to have photosensitivity * Taking medications that fluoresce * Have scars, any tattoos, rashes or other disruption/discoloration on the left volar forearm

Locations (1)

Blue Cross Blue Shield of Louisiana

Baton Rouge, Louisiana, United States

Outcomes

Primary Outcomes

To compare the accuracy of SCOUT DS versus random capillary glucose and several diabetes risk assessment questionnaires for detection of HbA1c-defined dysglycemia.

Time frame: one week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.